Aaron Crapster

at Vibliome Therapeutics, LLC
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Bozeman, Montana, United States, US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
      • Feb 2023 - Present

      At Vibliome, I lead efforts in target selection, discovery biology, DMPK, in vivo pharmacology, and preclinical safety.

      • Jun 2019 - Feb 2023

  • SPARK Drug Discovery
    • Stanford University, School of Medicine
    • Project Leader
      • Jan 2013 - Jun 2019

    • United States
    • Higher Education
    • 700 & Above Employee
    • Male Contraceptive Initiative Fellow
      • Jul 2018 - May 2019

      Demonstrated that homeodomain-interacting protein kinase 4 (HIPK4) is essential for spermiogenesis and male fertility in mice using knockout mouse models and cultured cells. I found that HIPK4 regulates F-actin dynamics in key structures that shape the sperm head as it transforms from a round to elongated spermatid. male fertility, sperm assessment, electron microscopy, histology, immunofluorescence, phosphoproteomics, microarray analysis, drug development Demonstrated that homeodomain-interacting protein kinase 4 (HIPK4) is essential for spermiogenesis and male fertility in mice using knockout mouse models and cultured cells. I found that HIPK4 regulates F-actin dynamics in key structures that shape the sperm head as it transforms from a round to elongated spermatid. male fertility, sperm assessment, electron microscopy, histology, immunofluorescence, phosphoproteomics, microarray analysis, drug development

    • United States
    • Higher Education
    • 700 & Above Employee
    • American Cancer Society Postdoctoral Fellow
      • Jul 2013 - Jul 2016

      As a postdoctoral fellow at Stanford University, I used chemical genetics, quantitative proteomics, and standard techniques in molecular/cellular/chemical biology and biochemistry to study kinase signaling and activation of the Hedgehog pathway. I also validated a set of proprietary, small molecule kinase inhibitors developed in collaboration with Spacefill Enterprises, LLC, and explored the links between our kinase of interest and a variety of cancers in cultured cell lines. As a postdoctoral fellow at Stanford University, I used chemical genetics, quantitative proteomics, and standard techniques in molecular/cellular/chemical biology and biochemistry to study kinase signaling and activation of the Hedgehog pathway. I also validated a set of proprietary, small molecule kinase inhibitors developed in collaboration with Spacefill Enterprises, LLC, and explored the links between our kinase of interest and a variety of cancers in cultured cell lines.

    • Higher Education
    • 700 & Above Employee
    • Graduate Student
      • Aug 2007 - Jul 2012

      As a graduate student at UW-Madison, I trained in the laboratory of Professor Helen Blackwell. My research was focused on the design, synthesis, and structural characterization of a class of peptidomimetics called peptoids. I discovered two new peptoid secondary structures (extended sheet and ribbon), and helped characterize two other new secondary structures, using NMR, X-ray crystallization, circular dichroism, and IR spectroscopy. As a graduate student at UW-Madison, I trained in the laboratory of Professor Helen Blackwell. My research was focused on the design, synthesis, and structural characterization of a class of peptidomimetics called peptoids. I discovered two new peptoid secondary structures (extended sheet and ribbon), and helped characterize two other new secondary structures, using NMR, X-ray crystallization, circular dichroism, and IR spectroscopy.

    • United States
    • Biotechnology Research
    • 700 & Above Employee
    • Research Assistant, Biochemical Engineer
      • 2006 - 2007

      • Analyzed liquid chromatography purification of antibody therapeutics during a scale-up process. • Validated the viral clearance and column lifetimes at each step of the purification. • Analyzed liquid chromatography purification of antibody therapeutics during a scale-up process. • Validated the viral clearance and column lifetimes at each step of the purification.

Education

  • Marine Biological Laboratories, Woods Hole, MA
    Frontiers of Reproduction, molecular mechanisms of reproductive biology
    2018 - 2018
  • University of Wisconsin-Madison
    Doctor of Philosophy (Ph.D.), Chemistry
    2007 - 2012
  • St. Mary's College of Maryland
    B.A, Chemistry, Biology
    2002 - 2006

Community

You need to have a working account to view this content. Click here to join now